Compare FBYD & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FBYD | CBLL |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 821.0M | 865.4M |
| IPO Year | N/A | N/A |
| Metric | FBYD | CBLL |
|---|---|---|
| Price | $4.37 | $20.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.67 |
| AVG Volume (30 Days) | 127.1K | ★ 284.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $37.44 |
| Revenue Next Year | N/A | $27.72 |
| P/E Ratio | $268.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.71 | $10.01 |
| 52 Week High | $29.02 | $26.04 |
| Indicator | FBYD | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 36.07 | 46.87 |
| Support Level | $3.71 | $19.49 |
| Resistance Level | $5.09 | $20.72 |
| Average True Range (ATR) | 0.75 | 1.08 |
| MACD | 0.21 | -0.09 |
| Stochastic Oscillator | 28.20 | 47.32 |
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.